Neurocrine Biosciences rare disease drug possibly tied to safety issues, experts say New therapy for Prader-Willi syndrome is linked to reports of deaths, severe side effects

https://www.statnews.com/2026/08/12/neurocrine-biosciences-vykat-prader-willi/ By Adam FeuersteinAug. 12, 2026 Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and biotechnology.